http___metro-portal.hr_napravljen-krvni-test-za-alzheimerovu-bolest_83730_1.xml
1.1 2.1 2.2 3.1 3.2 3.3 4.1 6.1 7.1 8.1 8.2 9.1 10.1 11.1 12.1 13.1 13.2 13.3 15.1
Affordable health care for all Increase Access to Affordable Health Care for All: My first experience dealing with the challenges facing our health care system was when I worked for Legal Aid as a community college student. I witnessed the stress that people experience when they do not have access to health care. Medical bills can create a downward spiral of debt and other tragic consequences in the lives of families. It was my job to do all I could to get these people back on solid financial ground. Source: 2012 House campaign website, bonamiciforcongress.com Sponsored merging Alzheimers diagnosis and care benefit. Bonamici co-sponsored HOPE for Alzheimer's Act Congressional Summary:The purpose of this Act is to increase diagnosis of Alzheimer's disease and related dementias, leading to better care and outcomes for Americans living with Alzheimer's disease and related dementias. Congress makes the following findings: - As many as half of the estimated 5.2 million Americans with Alzheimer's disease have never received a diagnosis. - An early and documented diagnosis and access to care planning services leads to better outcomes for individuals with Alzheimer's disease. - Combining the existing Medicare benefits of a diagnostic evaluation and care planning into a single package of services would help ensure that individuals receive an appropriate diagnosis as well as critical information about the disease and available care options. Proponent's argument for bill: (The Alzheimer's Association, alz.org). The "Health Outcomes, Planning, and Education (HOPE) for Alzheimer's Act" (S.709/H.R. 1507) is one of the Alzheimer's Association's top federal priorities for the 113th Congress. The HOPE for Alzheimer's Act would improve diagnosis of Alzheimer's disease and increase access to information on care and support for newly diagnosed individuals and their families. It would also ensure that an Alzheimer's or dementia diagnosis is documented in the individual's medical record. Page last updated: Aug 01, 2014
1.1 2.1 3.1 4.1 5.1 6.1 7.1
Napravljen krvni test za Alzheimerovu bolest Američki znanstvenici su razvili krvni test koji može precizno predvidjeti pojavu Alzheimerove bolesti Podaci istraživača s Georgetown University u Washingtonu pokazuju kako je praćenjem prisutnosti 10 lipida u krvi moguće uz 90%-tnu točnost predvidjeti rizik za pojavu Alzheimerove bolesti u sljedeće 3 godine. Ovi nalazi su prikupljeni tijekom 5 godina od 525 ispitanika starijih od 70 godina, a sada slijede opsežnija klinička istraživanja. Procjenjuje se kako s Alzheimerovom bolešću i drugimo oblicima demencije sada živi 44 milijuna. Do 2050. godine bi se ova brojka trebala utrostručiti. Alzheimerova bolest napada mozak i više od 10 godina prije pojave prvih simptoma, što znatno otežava rad na razvoju potrebnih lijekova.